Home Newsfeeds B. Riley Securities Maintains Buy on New York Mortgage Trust, Lowers Price Target to $5

B. Riley Securities Maintains Buy on New York Mortgage Trust, Lowers Price Target to $5

B. Riley Securities analyst Matt Howlett maintains New York Mortgage Trust (NASDAQ:NYMT) with a Buy and lowers the price target from $5.5 to $5.

byBenzinga Newsdesk

October 25, 2022

1 minute read

B. Riley Securities analyst Matt Howlett maintains New York Mortgage Trust (NASDAQ:NYMT) with a Buy and lowers the price target from $5.5 to $5.

M&A
News

SVES, An Off-Price Apparel Distribution Company, Announces Plans To Go Public Via Merger With Relativity Acquisition Corp.

By Happy Mohamed

February 13, 9:55 AM

SVES has entered into a business combination agreement with Relativity Acquisition Corp. (NASDAQ:RACY) The combined company, which will be named SVES, Inc., will have an implied Pro-forma enterprise value of

RACY

Dolphin Entertainment Shares Rise After Q1 Earnings Results: The Details

By Dylan Berman

May 15, 10:44 AM

During Tuesday's after-market session, Dolphin Entertainment announced first-quarter earnings that included $15.24 million in revenue, representing a 54% year-over-year increase. The company reported a loss of two cents per share, which was up from a loss of 23 cents per share in the prior year's quarter.

DLPN

Andelyn Biosciences Selected By Ultragenyx For Late-Stage Process Performance Qualification Manufacturing Of Novel Gene Therapy For Sanfilippo Syndrome

By Happy Mohamed

December 18, 10:38 AM

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ:RARE) to

RARE